NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Get Started
$69.01 -0.59 (-0.85 %)
(As of 04/24/2019 04:20 AM ET)
Previous Close$69.60
Today's Range$68.87 - $69.78
52-Week Range$57.41 - $70.06
Volume3.26 million shs
Average Volume3.83 million shs
Market Capitalization$59.34 billion
P/E Ratio23.24
Dividend Yield2.47%
Beta0.79
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. The company also provides home care products comprising dishwashing detergents, household cleaners, and fabric conditioners; pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. Its principal global and regional trademarks include Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The company markets and sells its oral, personal, and home care products to various retailers, wholesalers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
Current SymbolNYSE:CL
Previous Symbol
CUSIP19416210
CIK21665
Webwww.colgatepalmolive.comen-us
Phone212-310-2000

Debt

Debt-to-Equity Ratio32.25
Current Ratio1.14
Quick Ratio0.76

Price-To-Earnings

Trailing P/E Ratio23.24
Forward P/E Ratio24.39
P/E Growth4.55

Sales & Book Value

Annual Sales$15.54 billion
Price / Sales3.82
Cash Flow$3.5756 per share
Price / Cash Flow19.30
Book Value$0.23 per share
Price / Book300.04

Profitability

EPS (Most Recent Fiscal Year)$2.97
Net Income$2.40 billion
Net Margins15.44%
Return on Equity25,268.29%
Return on Assets20.50%

Miscellaneous

Employees34,500
Outstanding Shares859,810,000
Market Cap$59.34 billion
Next Earnings Date4/26/2019 (Confirmed)
OptionableOptionable

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, March 14th. Investors of record on Friday, April 19th will be given a dividend of $0.43 per share on Wednesday, May 15th. This represents a $1.72 annualized dividend and a yield of 2.49%. The ex-dividend date is Wednesday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.42. View Colgate-Palmolive's Dividend History.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its Board of Directors has authorized a share repurchase plan on Monday, June 18th 2018, which allows the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) announced its earnings results on Friday, January, 25th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.73 by $0.01. The business earned $3.81 billion during the quarter, compared to the consensus estimate of $3.78 billion. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business's quarterly revenue was down 2.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.75 earnings per share. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, April 26th 2019. View Earnings Estimates for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, April 26th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for CL?

17 brokerages have issued 1 year target prices for Colgate-Palmolive's shares. Their forecasts range from $54.00 to $75.00. On average, they expect Colgate-Palmolive's share price to reach $65.7333 in the next year. This suggests that the stock has a possible downside of 4.7%. View Analyst Price Targets for Colgate-Palmolive.

What is the consensus analysts' recommendation for Colgate-Palmolive?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 11 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:
  • 1. According to Zacks Investment Research, "Colgate underperformed the industry in the past year owing to a soft margins trend and a bleak outlook for 2019. The company expects earnings to be soft in 2019 owing to higher raw material costs, increase in tax rate, and uncertainties in the global markets and currency rates. Additionally, the company continued its soft margins trend in the fourth quarter, which is likely to persist in 2019. Higher raw and packaging material costs are mainly to be blamed for the company’s soft margins. However, Colgate expects strong sales growth in 2019 backed by accelerated investments in brands, higher pricing and strong innovation. Moreover, its innovation efforts marked by the re-launch of Colgate Total and Hill’s Science Diet, as well as expansion of the naturals range, remain impressive. Notably, the company reported top and bottom line beat in fourth-quarter 2018, retaining its meet or beat earnings track record." (4/23/2019)
  • 2. Jefferies Financial Group Inc analysts commented, "We maintain our Hold / $61 PT following the Colgate Total relaunch event in NYC (1/31). Despite clinical advances, significant investment, and improved price/mix, we are less certain the brand is a game changer given consumers’ shift from total care toothpaste products and relatively indistinguishable packaging vs. the existing brand. The stock’s recent bounce leaves valuation full at 22.5x NTM P/E (in-line w/hist. 5% prem. to HPC stocks) – Hold. We attended the Colgate Total re-launch event in NYC (1/31), which was primarily targeted toward media and valued product influencers, that sets the stage for the brand’s official roll-out. We are less certain this is a game-changer as total claim toothpaste brands have lost share in the US and the product’s packaging is relatively indistinguishable vs. its existing namesake product (see Chart 1)." (2/1/2019)
  • 3. Wells Fargo & Co analysts commented, "We especially enjoyed the surprise performance by JoJo and sneak peek at CL’s Super Bowl ad featuring Luke Wilson. We also spent time in CL’s innovation area and saw firsthand the benefits of CL’s extensive R&D including anti-sensitivity, instant neutralization of odors, incremental enamel protection and new flavors. It also helped us conceptualize the significant marketing and promotional support that the brand will receive and as such, we came away feeling better about the potential for success of the Total relaunch. However, we also note that the uptick in spending CL is taking across its entire portfolio to accelerate organic sales growth (we est. +80bps) is also pressuring EPS (which is expected to be down -MSD in FY19)." (1/31/2019)

Has Colgate-Palmolive been receiving favorable news coverage?

News coverage about CL stock has been trending somewhat positive recently, according to InfoTrie. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a news sentiment score of 1.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term.

Who are some of Colgate-Palmolive's key competitors?

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), Intel (INTC), Mcdonald's (MCD), AT&T (t), The Coca-Cola (KO), Walt Disney (DIS), Verizon Communications (VZ) and Exxon Mobil (XOM).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:
  • Mr. Ian M. Cook, Exec. Chairman (Age 66)
  • Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
  • Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
  • Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
  • Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.18%), Mondrian Investment Partners LTD (0.13%), Ronna Sue Cohen (0.10%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.09%), Gateway Investment Advisers LLC (0.08%) and LGT Capital Partners LTD. (0.08%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Which institutional investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Gyroscope Capital Management Group LLC, Douglass Winthrop Advisors LLC, LGT Capital Partners LTD., Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, Pennsylvania Trust Co, Palisade Asset Management LLC, Quantitative Systematic Strategies LLC and Strategic Financial Services Inc . Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive.

Which institutional investors are buying Colgate-Palmolive stock?

CL stock was purchased by a variety of institutional investors in the last quarter, including Ronna Sue Cohen, 6 Meridian, Cohen Klingenstein LLC, Mondrian Investment Partners LTD, Boston Advisors LLC, Pacer Advisors Inc., Isthmus Partners LLC and DNB Asset Management AS. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $69.01.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $59.34 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is http://www.colgatepalmolive.com/en-us.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]


MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  391 (Vote Outperform)
Underperform Votes:  780 (Vote Underperform)
Total Votes:  1,171
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Featured Article: Is it Safe to Invest in Commodities?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel